Avenue Therapeutics
is a selective receptor agonist that produces and activity receptor | Avenue Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
October 2022
Slide
9 of 30
Related slides by other companies
NeuroBo Pharmaceuticals
Securities Offering
October 2022
a novel protein coupled receptor agonist with potential for non alcoholic nash synthetic small molecule selective and suitable for oral administration i ale | NeuroBo Pharmaceuticals
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io